EP3515487
TVÍSÉRTÆK AND-MUC16-CD3-MÓTEFNI OG AND-MUC16-LYFJAAFLEIÐUR
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
22.9.2017EP published:
19.7.2023EP application number:
17784089.9
EP translation filed:
10.8.2023Grant published:
15.10.2023EPO information:
European Patent Register
Max expiry date:
21.9.2037Expiry date:
21.9.2026Next due date:
30.9.2026
Title in English:
BI SPECIFIC ANTI-MUC16-CD3 ANTIBODIES AND ANTI-MUC16 DRUG CONJUGATESLanguage of the patent:
English
Timeline
Today
22.9.2017EP application
19.7.2023EP Publication
10.8.2023Translation submitted
15.10.2023Registration published
21.9.2026Expires
Owner
Name:
Regeneron Pharmaceuticals, Inc.Address:
777 Old Saw Mill River Road, Tarrytown, NY 10591, US
Inventor
Name:
HABER, LauricAddress:
Tarrytown, New York 10591, US
Name:
SMITH, EricAddress:
Tarrytown, New York 10591, US
Name:
KELLY, MarcusAddress:
Tarrytown, New York 10591, US
Name:
KIRSHNER, Jessica R.Address:
Tarrytown, New York 10591, US
Name:
COETZEE, SandraAddress:
Tarrytown, New York 10591, US
Name:
CRAWFORD, AlisonAddress:
Tarrytown, New York 10591, US
Name:
NITTOLI, ThomasAddress:
Tarrytown, New York 10591, US
Name:
LIU, YashuAddress:
Tarrytown, New York 10591, US
Agent
Name:
Tego IP ehf.Address:
Pósthólf 8129, 128, Reykjavík,
Priority
Number:
201662399249 PDate:
23.9.2016Country:
US
Number:
201762558711 PDate:
14.9.2017Country:
US
Classification
Categories:
A61K 39/395, C07K 16/28, C07K 16/30, C07K 16/44, C07K 16/46
Annual fees
Number
Paid
Expires
Payer
Number: 7
Paid: 15.9.2023
Expires: 21.9.2024
Payer: Árnason Faktor ehf.
Number: 8
Paid: 22.8.2024
Expires: 21.9.2025
Payer: Árnason Faktor ehf.
Number: 9
Paid: 15.9.2025
Expires: 21.9.2026
Payer: Árnason Faktor ehf.